Cargando…

Targeted Next Generation Sequencing and Diagnosis of Congenital Hemolytic Anemias: A Three Years Experience Monocentric Study

Congenital hemolytic anemias (CHAs) are heterogeneous and rare disorders caused by alterations in structure, membrane transport, metabolism, or red blood cell production. The pathophysiology of these diseases, in particular the rarest, is often poorly understood, and easy-to-apply tools for diagnosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fermo, Elisa, Vercellati, Cristina, Marcello, Anna Paola, Keskin, Ebru Yilmaz, Perrotta, Silverio, Zaninoni, Anna, Brancaleoni, Valentina, Zanella, Alberto, Giannotta, Juri A., Barcellini, Wilma, Bianchi, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176228/ https://www.ncbi.nlm.nih.gov/pubmed/34093240 http://dx.doi.org/10.3389/fphys.2021.684569

Ejemplares similares

Congenital Hemolytic Anemias: Is There a Role for the Immune System?
por: Zaninoni, Anna, et al.
Publicado: (2020)

Use of Laser Assisted Optical Rotational Cell Analyzer (LoRRca MaxSis) in the Diagnosis of RBC Membrane Disorders, Enzyme Defects, and Congenital Dyserythropoietic Anemias: A Monocentric Study on 202 Patients
por: Zaninoni, Anna, et al.
Publicado: (2018)

New Insights in Autoimmune Hemolytic Anemia: From Pathogenesis to Therapy
por: Barcellini, Wilma, et al.
Publicado: (2020)

Cytokine polymorphisms in patients with autoimmune hemolytic anemia
por: Zaninoni, Anna, et al.
Publicado: (2023)

Intravascular hemolysis and multitreatment predict thrombosis in patients with autoimmune hemolytic anemia
por: Fattizzo, Bruno, et al.
Publicado: (2022)

PB2546: DIAGNOSTIC POWER OF ERYTHROCYTE AND RETICULOCYTE AUTOMATIC PARAMETERS IN THE SCREENING FOR CONGENITAL HEMOLYTIC ANEMIAS
por: Bianchi, Paola, et al.
Publicado: (2023)

Small Paroxysmal Nocturnal Hemoglobinuria Clones in Autoimmune Hemolytic Anemia: Clinical Implications and Different Cytokine Patterns in Positive and Negative Patients
por: Fattizzo, Bruno, et al.
Publicado: (2020)

How will next generation sequencing (NGS) improve the diagnosis of congenital hemolytic anemia?
por: Bianchi, Paola, et al.
Publicado: (2020)

Effect of primary lesions in cytoskeleton proteins on red cell membrane stability in patients with hereditary spherocytosis
por: Vercellati, Cristina, et al.
Publicado: (2022)

P1526: AUTOIMMUNE HEMOLYTIC ANEMIAS: RELATIONSHIP BETWEEN SINGLE NUCLEOTIDE POLYMORPHISMS OF CYTOKINE GENES AND CLINICAL/HEMATOLOGICAL PARAMETERS
por: Zaninoni, A., et al.
Publicado: (2022)

Bortezomib in autoimmune hemolytic anemia and beyond
por: Pasquale, Raffaella, et al.
Publicado: (2021)

Infectious Complications in Autoimmune Hemolytic Anemia
por: Giannotta, Juri Alessandro, et al.
Publicado: (2021)

Hereditary Xerocytosis due to Mutations in PIEZO1 Gene Associated with Heterozygous Pyruvate Kinase Deficiency and Beta-Thalassemia Trait in Two Unrelated Families
por: Fermo, Elisa, et al.
Publicado: (2017)

Clinical and Molecular Spectrum of Glucose-6-Phosphate Isomerase Deficiency. Report of 12 New Cases
por: Fermo, Elisa, et al.
Publicado: (2019)

Confounding factors in the diagnosis and clinical course of rare congenital hemolytic anemias
por: Fattizzo, Bruno, et al.
Publicado: (2021)

Difficult Cases of Autoimmune Hemolytic Anemia: A Challenge for the Internal Medicine Specialist
por: Fattizzo, Bruno, et al.
Publicado: (2020)

Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectives
por: Barcellini, Wilma, et al.
Publicado: (2019)

PB1990: GLYCOLYTIC ACTIVITY AND EFFECT OF EX-VIVO TREATMENT WITH THE PYRUVATE KINASE (PK) ACTIVATOR AG-946 IN RED BLOOD CELLS FROM LOW-RISK MYELODYSPLASTIC SYNDROMES PATIENTS: A PROOF-OF-CONCEPT STUDY
por: Fattizzo, Bruno, et al.
Publicado: (2023)

Efficacy of recombinant erythropoietin in autoimmune hemolytic anemia: a multicenter international study
por: Fattizzo, Bruno, et al.
Publicado: (2020)

Evaluation of the main regulators of systemic iron homeostasis in pyruvate kinase deficiency
por: Zaninoni, Anna, et al.
Publicado: (2023)

Autoimmune Hemolytic Anemia as a Complication of Congenital Anemias. A Case Series and Review of the Literature
por: Motta, Irene, et al.
Publicado: (2021)

The Immunomodulatory Effect and Clinical Efficacy of Daratumumab in a Patient With Cold Agglutinin Disease
por: Zaninoni, Anna, et al.
Publicado: (2021)

‘Gardos Channelopathy’: a variant of hereditary Stomatocytosis with complex molecular regulation
por: Fermo, Elisa, et al.
Publicado: (2017)

P1583: TRANSFUSIONS IN AUTOIMMUNE HEMOLYTIC ANEMIA: FREQUENCY AND CLINICAL SIGNIFICANCE OF ALLOIMMUNIZATION
por: Versino, Francesco, et al.
Publicado: (2023)

Case report: Transfusion independence and abolition of extravascular hemolysis in a PNH patient treated with pegcetacoplan
por: Fattizzo, Bruno, et al.
Publicado: (2022)

New Insights in the Pathogenesis of Autoimmune Hemolytic Anemia
por: Barcellini, Wilma
Publicado: (2015)

Mesenchymal Stem Cells in Aplastic Anemia and Myelodysplastic Syndromes: The “Seed and Soil” Crosstalk
por: Fattizzo, Bruno, et al.
Publicado: (2020)

The Changing Landscape of Autoimmune Hemolytic Anemia
por: Barcellini, Wilma, et al.
Publicado: (2020)

Diagnosis and Management of Autoimmune Hemolytic Anemias
por: Barcellini, Wilma, et al.
Publicado: (2022)

Monitoring of Patients with Autoimmune Cytopenias during Sars-Cov-2 Vaccination Campaign: The Experience of a Reference Center
por: Fattizzo, Bruno, et al.
Publicado: (2021)

P1555: IRON CHELATION THERAPY IN CONGENITAL HEMOLYTIC ANEMIAS: AN ITALIAN SINGLE CENTER STUDY
por: Bosi, A., et al.
Publicado: (2022)

The choice of new treatments in autoimmune hemolytic anemia: how to pick from the basket?
por: Berentsen, Sigbjørn, et al.
Publicado: (2023)

Pyruvate Kinase Deficiency: Current Challenges and Future Prospects
por: Fattizzo, Bruno, et al.
Publicado: (2022)

Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia
por: Barcellini, W., et al.
Publicado: (2015)

Editorial: Pathophysiology of Rare Hemolytic Anemias
por: van Wijk, Richard, et al.
Publicado: (2020)

Efficacy and Immunomodulating Properties of Eltrombopag in Aplastic Anemia following Autologous Stem Cell Transplant: Case Report and Review of the Literature
por: Bortolotti, Marta, et al.
Publicado: (2022)

Are Patients With Autoimmune Cytopenias at Higher Risk of COVID-19 Pneumonia? The Experience of a Reference Center in Northern Italy and Review of the Literature
por: Barcellini, Wilma, et al.
Publicado: (2021)

Autoimmune Complications in Hematologic Neoplasms
por: Barcellini, Wilma, et al.
Publicado: (2021)

Paroxysmal Nocturnal Hemoglobinuria in the Context of a Myeloproliferative Neoplasm: A Case Report and Review of the Literature
por: Giannotta, Juri Alessandro, et al.
Publicado: (2021)

Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature
por: Fattizzo, Bruno, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b26b5qviaku1g83ginbf5eug1u